Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B
Patricia Gita Naully; Marselina Irasonia Tan; Agustiningsih Agustiningsih; Caecilia Sukowati; Ernawati Arifin Giri-Rachman;
10.1016/j.aohep.2024.101533
Prevalence of occult hepatitis B virus infection and characterisation of hepatitis B surface antigen mutants among adults in western Croatia
Marina Bubonja-¿onje; Dolores Peru¿; Maja Abram; Bojana Mohar-Vitezi¿;
Ann Hepatol. 2024;29:
Improved bone and renal safety in younger tenofovir disoproxil fumarate experienced chronic hepatitis B patients after switching to tenofovir alafenamide or entecavir
Fa- Da Wang; Jing Zhou; Lan-Qing Li; Yu-Jing Li; Meng-Lan Wang; Ya-Chao Tao; Dong-Mei Zhang; Yong-Hong Wang; En-Qiang Chen;
Ann Hepatol. 2023;28: